Merck to Present New Data on Investigational Chronic Hepatitis C Treatment

Merck to Present New Data on Investigational Chronic Hepatitis C Treatment … KENILWORTH, N.J., Oct 20, 2015 (BUSINESS WIRE) — Merck MRK, +1.67% known as MSD outside the United States and Canada, today announced that new data from clinical trials … Continue reading

U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral

U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral … This submission affirms the company's commitment to seeking access to curative* therapy for patients living with chronic HCV infection (*curative is defined as when the virus is no longer … Continue reading